Transforming Growth Factor Beta 1 Market

Transforming growth factor beta 1 or TGF-?1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-?1 is encoded by the TGFB1 gene

Transforming Growth Factor Beta 1 Market contains market size and forecasts of Transforming Growth Factor Beta 1 in global, including the following market information:

Global Transforming Growth Factor Beta 1 Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Transforming Growth Factor Beta 1 Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Transforming Growth Factor Beta 1 companies in 2021 (%)

The global Transforming Growth Factor Beta 1 market was valued at 1500.4 million in 2021 and is projected to reach US$ 3041.7 million by 2028, at a CAGR of 10.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pirfenidone Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Transforming Growth Factor Beta 1 include Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co and Formation Biologics Inc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Transforming Growth Factor Beta 1 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Transforming Growth Factor Beta 1 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Transforming Growth Factor Beta 1 Market Segment Percentages, by Type, 2021 (%)

Pirfenidone

Galunisertib

Others

Global Transforming Growth Factor Beta 1 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Transforming Growth Factor Beta 1 Market Segment Percentages, by Application, 2021 (%)

IPF

Cancer

Others

Global Transforming Growth Factor Beta 1 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Transforming Growth Factor Beta 1 Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Transforming Growth Factor Beta 1 revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Transforming Growth Factor Beta 1 revenues share in global market, 2021 (%)

Key companies Transforming Growth Factor Beta 1 sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Transforming Growth Factor Beta 1 sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Shionogi Ltd

Acceleron Pharma Inc

Genzyme Corp

Isarna Therapeutics GmbH

Scholar Rock

Sirnaomics Inc

Eli Lilly and Co

Formation Biologics Inc

Novartis AG